If trials on humans go the way they did on rats and pigs, a stem cell therapy to treat patients with Lou Gehrig’s disease could be on the market in four years…
Human stem cell therapy could be on market in four years, researcher says

If trials on humans go the way they did on rats and pigs, a stem cell therapy to treat patients with Lou Gehrig’s disease could be on the market in four years…